Reflexion is being developed in public-facing stages. This roadmap uses quarterly milestones to separate completed prototype work, current public progress, and future development plans.
Development year
Prototype concept, workflow direction, and early consolidation.
Q2
CompletedReflexion began as a non-clinical structured reflection prototype exploring how AI could organize emotionally difficult narratives into clearer patterns, summaries, and follow-up prompts.
Q3
CompletedThe project direction moved from a general reflection idea toward a clearer user-facing workflow.
Q4
CompletedThe prototype direction was consolidated around structured reflection rather than therapy, diagnosis, or emotional reassurance.
Development year
Public positioning, visible prototype, and connected foundation planning.
Q1
CompletedThe project was reframed as a non-clinical affective computing and human-facing AI prototype.
Q2
Live nowThe current public version makes Reflexion visible as a structured reflection prototype.
The public demo is a static workflow preview using sample data. It shows interaction flow, signal categories, and report structure. It does not include live backend analysis, stored reflection content, saved reports, or clinical/legal authority.
Q3
Planned nextThe next phase focuses on turning the static workflow into a connected product foundation.
Q4
PlannedThis phase focuses on making structured reflection easier to review after the initial session.
Development year
Pilot-readiness, evaluation, and cross-platform direction.
Q1
Future directionThis phase prepares Reflexion for more structured feedback and responsible human-facing AI evaluation.
Q2+
Future directionLonger-term work may support mobile capture and desktop review.
Planned features remain roadmap items until implemented. Live backend behavior, saved reflection content, cross-device sync, downloadable reports, and production data handling should not be presented as current demo features.
The current public site and demo are evidence of direction, workflow, and interface design. They do not claim live clinical, legal, or production data authority.